--- title: 'Regional Sales Director - Attruby at BridgeBio Pharma' canonical: 'https://feeny.ai/job/regional-sales-director-attruby-bridgebio-pharma-united-states-1n8vfwwncewy' type: 'job' last_seen: '2026-10-28' --- # Regional Sales Director - Attruby at BridgeBio Pharma - **Company:** BridgeBio Pharma - **Location:** United States - **Compensation:** $235k–$265k - **Work type:** remote - **Posted:** 2026-10-21 - **Last confirmed live:** 2026-10-28 - **Apply:** https://job-boards.greenhouse.io/bridgebio/jobs/5271743007 ## Job description Mavericks Wanted When was the last time you achieved the impossible? If that thought feels overwhelming, you might want to pause here, but if it sparks excitement...read on In 2015, we pioneered a “moneyball for biotech” approach, pooling projects and promising early-stage research from academia together under one financial umbrella to reduce risk and unleash innovation. This model allows science and small teams of experts to lead the way. We build bridges to groundbreaking advancements in rare disease, and develop life-changing medicines for patients with unmet needs as fast as humanly possible. Together we define white space, push boundaries, and empower people to solve problems. If you're someone who defies convention, join us and work alongside some of the most respected minds in the industry. Together, we'll ask "why not?" and help reengineer the future of biopharma. At BridgeBio, we value curiosity and experimentation—including the ethical & thoughtful use of AI to improve clarity, speed, and quality of work. ## What You'll Do BridgeBio is growing our sales leadership team and seeking Regional Sales Directors for high-impact, front-line leadership roles critical to our success They will be a talented leader with the strategic acumen, commercial capabilities, and leadership skills to build and motivate a high-performing sales team to execute product launches with sustained excellence. They will bring experience in scaling and launching successful drugs. In doing such, they will bring passion, urgency, and a get-it-done attitude to treating unmet needs in patients. ## Responsibilities - Build sales force, managing, motivating and inspiring teams from pre-launch through commercialization, including launch readiness and post-approval activities for the sales force - Achieve results through Sales team with a successful commercial launch for Attruby, working closely with commercial and medical counterparts to ensure alignment and success - Be accountable for your Regional Sales team for achieving sales performance targets - Actively review Regional Sales team performance metrics Area Sales Director to ensure that the Regional Sales team is executing brand strategies and plans optimally and achieving maximum sales results for assigned geographies - Collaborate with marketing to create a differentiated and compelling product message and to develop and execute marketing plans based on needs within region. - Establish, build, and maintain relationships with Key Opinion Leaders in partnership with Marketing and Medical Affairs. Expand relationships with KOLs and customers to identify opportunities to increase advocacy for brands and the company Critical Leadership Capabilities - - Leading People - Communicate the vision and purpose of the organization with enthusiasm and passion - Enlist industry-leading leadership team to reinforce the organization’s purpose, culture, and values Exceptional Collaboration - - Promote cross-organizational collaboration, transparency and execution to build alignment around the organization’s purpose, vision, and direction - Foster open communication and debate throughout the Regional Sales Team resolving different objectives to achieve a common purpose Driving Results - - Act to surpass team goals and achieve results through others through motivation and inspiring to seize opportunities to extend the limits of what is possible - Exhibit strong business acumen by setting continually higher goals for the team that are ambitious but achievable, holding the team accountable to their commitments - Identify and act on new opportunities that enable performance targets to be exceeded - Be a business operator and innovate with ideas that are grounded with quantitative and qualitative insights People Development - - Empower and encourage team to continuously learn to strengthen and develop new skills - Challenge team to push their boundaries of comfort and provide the necessary support to enable their success to achieve performance goals ## Who You Are - 8-10 years in pharmaceutical/biotech - 3-5 years of front-line leadership - Cardiology experience is preferred - Demonstrated success building and leading sales force from scratch with progressively greater scope and responsibility - Strong sales leader; Proven success in building and leading sales teams that have consistently achieved superlative results, with evidence of success in mentoring, motivating, and contributing to the professional development of a diverse commercial team, particularly in a rapidly changing and fast-paced environment - Product/indication launch experience; Track record of successfully launching new products and/or new indications into highly competitive markets At BridgeBio, we strive to provide a market-competitive total rewards package, including base pay, an annual performance bonus, company equity, and generous health benefits. Below is the anticipated salary range for candidates for this role who will work in California. The final salary offered to a successful candidate will depend on several factors that may include but are not limited to the type and length of experience within the job, type, and length of experience within the industry, educational background, location of residence and performance during the interview process. BridgeBio is a multi-state employer, and this salary range may not reflect positions based in other states. Salary $235,000—$265,000 USD As a global company, our comprehensive benefits may vary based on location.  We have high expectations for our team members. We make sure those working hard for patients are rewarded and cared for in return. For BridgeBio Full-Time U.S Based Roles: Financial & Rewards - Market-leading compensation - 401(k) with employer match - Employee Stock Purchase Program (ESPP) - Pre-tax commuter benefits (transit and parking) - Referral bonus for hired candidates - Subsidized lunch and parking on in-office days Health & Well-Being - 100% employer-paid medical, dental, and vision premiums for you and your dependents - Health Savings Account (HSA) with annual employer contributions, plus Flexible Spending Accounts (FSA) - Fertility & family-forming benefits - Expanded mental health support (therapy and coaching resources) - Hybrid work model with flexibility - Flexible, “take-what-you-need” paid time off and company-paid holidays - Comprehensive paid medical and parental leave to care for yourself and your family Skill Development & Career Paths: - People are part of our growth and success story - from discovery to active drug trials and FDA pipelines, there are endless opportunities for skill development and internal mobility - We provide career pathing through regular feedback, continuous education and professional development programs via LinkedIn Learning, LifeLabs, & BetterUp Coaching - We celebrate strong performance with financial rewards, peer-to-peer recognition, and growth opportunities By applying, you acknowledge that BridgeBio will process your personal information as described in our [Global Candidate Privacy Notice](https://bridgebio.com/bridgebio-global-candidate-privacy-notice). ## About BridgeBio Pharma ## Company Overview - **One-liner**: BridgeBio Pharma develops transformative medicines for genetic conditions, using a decentralized hub-and-spoke model to accelerate drug development from early research to commercialization. - **Entity Type**: Public (Nasdaq: BBIO) - **Headquarters**: Palo Alto, California, USA (with hybrid offices in San Francisco, CA) - **Founded**: Not explicitly stated in provided sources; the company references “over the past 10 years” as of 2026, suggesting founding around 2015–2016. - **Founders**: Not publicly available from provided sources. ## Core Business - **Primary industry**: Biotechnology / Genetic disease therapeutics - **Target customers**: Patients living with genetic conditions, healthcare providers, payers, and academic research partners - **Mission**: “To develop transformative medicines for genetic conditions” and “bridge the gap between advancements in genetic science and meaningful medicines for underserved patient populations.” ## Products & Services BridgeBio’s pipeline includes both approved therapies and investigational candidates across dozens of indications. Key offerings: - **Acoramidis**: Approved for transthyretin amyloidosis (ATTR) – a first-in-class treatment with $8B+ peak year sales potential. - **Infigratinib**: Phase 3 completed for achondroplasia; published in the *New England Journal of Medicine* (2026). - **BBP-418**: Investigational for Limb-Girdle Muscular Dystrophy Type 2I/R9 (LGMD2I/R9). - **Encaleret**: Investigational for Autosomal Dominant Hypocalcemia Type 1 (ADH1). - **BBP-812**: Investigational for Canavan Disease. - **BridgeBio Oncology Therapeutics (BBOT)**: Subsidiary focused on RAS and PI3Kα-driven cancers. - **GondolaBio**: Subsidiary developing bioavailable small molecule inhibitors for oncology. - **Other programs**: Covering hypochondroplasia, chronic hypoparathyroidism, and more. The company has received **3 FDA approvals** and has over **70+ peer-reviewed publications**. ## Market Standing - **Valuation / Market Cap**: Not explicitly stated in provided data; as a public company, current market cap can be found on financial platforms (e.g., ~$8B based on peak sales potential, but not a direct valuation number). - **Key Metric**: **3 FDA-approved medicines**; **2000+ patients enrolled** in global clinical trials; **6 Phase 3 trials** conducted over the past 10 years. - **Notable Investors / Partners**: Not detailed in provided sources, but the company partners with leading academic institutions to advance early-stage research. - **Growth Signals**: Recent publication of Phase 3 PROPEL 3 trial results in NEJM (June 2026); expansion into oncology via BBOT and GondolaBio; 100% of pipeline is first-in-class or best-in-class; 48 unique disease indications targeted. ## Competitive Advantages - **Hub-and-spoke model**: Decentralized structure where autonomous affiliate teams (spokes) focus on specific conditions, while a central hub provides clinical, regulatory, and commercial expertise. This enables speed, scalability, and risk reduction. - **First-in-class / best-in-class focus**: 100% of pipeline aims to be first or best in class, targeting underserved genetic conditions with clear biological rationale. - **Speed and adaptability**: The model allows rapid pivoting to the most promising opportunities, reducing development timelines compared to traditional biotech. - **Strong scientific foundation**: Over 70 peer-reviewed papers and collaborations with top academic institutions. ## Strategic Focus - **Advance late-stage pipeline**: Prioritize Phase 3 programs (e.g., infigratinib for achondroplasia, acoramidis for ATTR) and seek additional FDA approvals. - **Expand into oncology**: Leverage subsidiaries BBOT and GondolaBio to address RAS/PI3Kα-driven cancers. - **Maintain urgency**: “Every minute counts” – continue to operate with speed and autonomy to bring treatments to patients faster. - **Build on commercial success**: Leverage existing approved products to fund further R&D and expand global reach. ## Why Work Here - **Award-winning culture**: Named **#1 Best Place to Work** by BioSpace (2026, small biotech category) with an **88% employee engagement score** in 2025. - **Flexible work model**: Hybrid policy with offices in San Francisco and Palo Alto, CA; “flexible working model” emphasized. - **Compensation and benefits**: Market-leading pay, comprehensive healthcare, and strong emphasis on growth and internal mobility. - **Impact-driven mission**: Work on transformative treatments for genetic conditions where patient need is urgent – “Impatient for Patients” is a core mantra. - **Values**: Put patients first, let science speak, think independently, speak up, and act with urgency. The culture is described as “high on standards, low on convention.” - **Growth opportunities**: 113 open jobs (as of mid-2026) across functions including clinical, regulatory, manufacturing, commercial, and corporate; talent community available for future roles. ## Sources 1. [bridgebio.com](https://bridgebio.com/) – Home page with pipeline overview and $8B peak sales potential 2. [bridgebio.com/about](https://bridgebio.com/about) – Company description, hub-and-spoke model, and key metrics 3. [bridgebio.com/careers](https://bridgebio.com/careers) – Careers page with awards, culture, and benefits 4. [investor.bridgebio.com](https://investor.bridgebio.com/overview/default.aspx) – Investor relations overview, latest news, and corporate presentation 5. [job-boards.greenhouse.io/bridgebio](http://job-boards.greenhouse.io/bridgebio) – Current job listings (113 roles) and departmental categories ## Other roles at BridgeBio Pharma - [Senior Marketing Manager, Skeletal Dysplasia](https://feeny.ai/job/senior-marketing-manager-skeletal-dysplasia-bridgebio-pharma-san-francisco-sdpr3bac78fx) — San Francisco, CA / Palo Alto, CA - [Senior Field Medical Director, Strategic Operations](https://feeny.ai/job/senior-field-medical-director-strategic-operations-bridgebio-pharma-san-4150ptsdsp16) — San Francisco, CA - [BD&Ops Director / Sr. Director](https://feeny.ai/job/bd-ops-director-sr-director-bridgebio-pharma-palo-alto-ffv4vme42c72) — Palo Alto, CA - [Field Reimbursement Manager, Southwest - Skeletal Dysplasia](https://feeny.ai/job/field-reimbursement-manager-southwest-skeletal-dysplasia-bridgebio-pharma-fay16wzevn61) — United States - [Field Reimbursement Manager, Southeast - Skeletal Dysplasia,](https://feeny.ai/job/field-reimbursement-manager-southeast-skeletal-dysplasia-bridgebio-pharma-fxt0f3sdwdn4) — United States - [Field Reimbursement Manager, Midwest - Skeletal Dysplasia](https://feeny.ai/job/field-reimbursement-manager-midwest-skeletal-dysplasia-bridgebio-pharma-united-b7mx2yyg45rj) — United States - [Director, Field Reimbursement - East](https://feeny.ai/job/director-field-reimbursement-east-bridgebio-pharma-united-states-rbt720p8m8g3) — United States - [Senior Manager / Associate Director, Medical Information](https://feeny.ai/job/senior-manager-associate-director-medical-information-bridgebio-pharma-united-43ankxcabebt) — United States - [Director, Government Pricing & Contract Operations](https://feeny.ai/job/director-government-pricing-contract-operations-bridgebio-pharma-san-francisco-3drkp53atz53) — /san Francisco CA & Palo Alto, CA - [Senior Manager, Corporate Communications](https://feeny.ai/job/senior-manager-corporate-communications-bridgebio-pharma-palo-alto-95nq7sks6gtc) — Palo Alto, CA